GAS5 and diabetes mellitus: In 2015, Carter and colleagues first reported that serum lncRNA GAS5 decreases in patients with type 2 diabetes; the results indicated that individuals with absolute GAS5 < 10 ng/μl have almost twelve times higher odds of having diabetes.